Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

PRECIOUS-Gold gains as U.S. jobs data, virus fears fuel stimulus hopes

Published 11/26/2020, 11:48 AM
Updated 11/26/2020, 04:20 PM
© Reuters.

(Updates prices, adds European futures)
* ANZ maintains 12-month gold price target of $2,100/oz
* European stock futures rise on vaccine, stimulus optimism
* Interactive graphic tracking global spread of coronavirus:
open
* https://tmsnrt.rs/3aIRuz7 in an external browser

By Nakul Iyer
Nov 26 (Reuters) - Gold prices rose on Thursday, aided by a
weaker dollar, as investors bet that grim U.S. jobs data and
surging COVID-19 cases worldwide would spur authorities to
announce further stimulus measures.
Spot gold XAU= rose 0.5% to $1,815.30 per ounce by 0748
GMT. U.S. gold futures GCv1 were up 0.4% at $1,812.70.
"We've seen risk sentiment improve because of the optimism
over vaccines and those were the headwinds for gold," said
Harshal Barot, a senior research consultant for South Asia at
Metals Focus.
"But since the dollar continues to weaken, gold prices are
finding a little bit of support."
The dollar index .DXY edged down 0.1%, strengthening
gold's appeal to other currency holders. USD/
Barot said gold would find support at $1,795 per ounce and
likely trade sideways in the near-term, until a "convincing"
break above $1,850.
European stock futures rose as the market's euphoric mood
over COVID-19 vaccines and on the prospects for stimulus under
incoming President Joe Biden outweighed concerns around an
uptick in weekly U.S. jobless claims. MKTS/GLOB "The vaccine narrative has watered down gold's appeal
immensely and it will continue too until we finally move into an
inflationary world," said Stephen Innes, chief global market
strategist at financial services firm Axi.
U.S. Federal Reserve policymakers discussed how the central
bank's asset purchases could be adjusted to provide more support
to markets in the minutes to its Nov. 4 to 5 meeting.

Continued accommodative central bank policy, given the
widespread unavailability of a vaccine until the second half of
2021 and dollar weakness means gold is well supported, ANZ said
in a note, adding it maintains its 12-month price target of
$2,100 per ounce.
Gold is seen as a hedge against inflation likely to result
from large stimulus.
Silver XAG= rose 0.6% to $23.44 an ounce. Platinum XPT=
gained 0.3% to $966.74 and palladium XPD= was rose 1.9% at
$2,372.15.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.